Arqit Quantum Inc vs 10X Genomics Inc — how do they compare? Arqit Quantum Inc trades at $24.3 (market cap $424.79M), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: 10X Genomics Inc is far larger — about 17.9× Arqit Quantum Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Arqit Quantum Inc nearer its low. Which is the better fit depends on your goals.
| ARQQ | TXG | |
|---|---|---|
Market Cap | $424.79M | $7.61B |
Sector | Technology | Health |
52-Week High | $58.27 | $58.57 |
52-Week Low | $11.78 | $11.34 |
Enterprise Value | $398.10M | $7.14B |
Trailing returns across standard periods
Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.
Read more on ARQQ →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →